Marché mondial du traitement de la grippe H5N1 – Tendances et prévisions du secteur jusqu’en 2028

Analyse et perspectives du marché : marché mondial du traitement de la grippe H5N1

Le marché du traitement de la grippe H5N1 devrait connaître une croissance potentielle de 4,70 % au cours de la période de prévision de 2021 à 2028. La sensibilisation accrue de la population à la maladie est le facteur de la croissance du marché.

Le virus H5N1 infecte généralement plusieurs types d'oiseaux. Les souches de type A du virus de la grippe, dont le H5N1, provoquent la grippe aviaire. Le virus se propage parmi les oiseaux par leurs sécrétions nasales, leur salive, leurs excréments et leur alimentation .

La sensibilisation accrue à la grippe aviaire et les mesures visant à prévenir sa propagation devraient accélérer la croissance du marché au cours de la période de prévision de 2021 à 2028. De même, l'augmentation des épidémies de grippe aviaire dans l'industrie avicole et la sensibilisation accrue au diagnostic parmi les patients infectés devraient également favoriser la croissance du marché du traitement de la grippe H5N1. En outre, la propagation rapide de l'infection chez d'autres oiseaux et les personnes travaillant dans des élevages de volailles nécessitant un traitement médical devraient également stimuler le taux de croissance du marché. En outre, le meilleur diagnostic résultant de la sensibilisation accrue des patients infectés grâce à la représentation clinique et au financement gouvernemental élevé du secteur de la santé devrait également influencer la croissance du marché du traitement de la grippe H5N1 à l'échelle mondiale.

En outre, l’augmentation des initiatives gouvernementales visant à assurer un diagnostic précoce et une sensibilisation accrue aux maladies infectieuses sont susceptibles de créer diverses nouvelles opportunités qui auront un impact sur la croissance du marché du traitement de la grippe H5N1 au cours de la période de prévision de 2021 à 2028.

However, the lack of awareness in developing countries and resistance of the virus to existing anti-viral drugs are also expected to act as major restraints towards the growth of the H5N1 influenza disease treatment market, whereas the dearth of diagnostic facilities can challenge the growth of the target market in the above mentioned forecast period.

This H5N1 influenza disease treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the H5N1 influenza disease treatment market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global H5N1 Influenza Disease Treatment Market Scope and Market Size

The H5N1 influenza disease treatment market is segmented on the basis of treatment, drug type, symptoms, distribution channel and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

• Based on treatment, the H5N1 influenza disease treatment market can be segmented into antibiotics, antiviral agents, vaccines and immunoglobulins.
• On the basis of drug type, the H5N1 influenza disease treatment market can be segmented into antivirals, neuraminidase inhibitors, ion channelm2 blockers, combination treatment, prophylactic antibiotics, steroids and other Immunosuppressants, immunoglobulin, ribavirin and others.
• On the basis of symptoms, the H5N1 influenza disease treatment market can be segmented into high fever, cough, diarrhea, headache, sore throat, runny nose and muscle ache.
• On the basis of distribution channel, the H5N1 influenza disease treatment market can be segmented into institutional health centers, hospital pharmacies, clinics and online pharmacies.
• On the basis of end user, the H5N1 influenza disease treatment market is segmented into hospital, institutional health centers, clinics and others.

H5N1 Influenza Disease Treatment Market Country Level Analysis

The H5N1 influenza disease treatment market is analyzed and market size information is provided by country by treatment, drug type, symptoms, distribution channel and end user as referenced above.

The countries covered in the H5N1 influenza disease treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America leads the H5N1 influenza disease treatment market due to increase in public awareness favorable reimbursement. Asia-Pacific region is expected to expand at a significant growth rate in the forecast period of 2021 to 2028 because of the rise in awareness about diseases passed from birds and increase in healthcare expenditure.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The H5N1 influenza disease treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analyzed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and H5N1 influenza disease tretmentMarket Share Analysis

The H5N1 influenza disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to H5N1 influenza disease treatment market.

Français Les principaux acteurs couverts dans le rapport sur le marché du traitement de la grippe H5N1 sont GlaxoSmithKline plc, F. Hoffmann-La Roche Ltd., BIOCRYST PHARMACEUTICALS, INC., Sanofi, Gilead Sciences, Inc.,  Macleods Pharmaceuticals Ltd., Cipla Inc., Pfizer, Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan NV, Allergan, AbbVie Inc., Aurobindo Pharma, Bayer AG, Lupin, Cadila Pharmaceuticals, Abbott, AstraZeneca et Sun Pharmaceutical Industries Ltd., entre autres acteurs nationaux et mondiaux. Les données sur les parts de marché du traitement de la grippe H5N1 sont disponibles séparément pour le monde, l'Amérique du Nord, l'Amérique du Sud, l'Europe, l'Asie-Pacifique (APAC) et le Moyen-Orient et l'Afrique (MEA). Les analystes de DBMR comprennent les atouts concurrentiels et fournissent une analyse concurrentielle pour chaque concurrent séparément.

SKU-61683